Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Group Regulatory News (PGH)

Share Price Information for Personal Group (PGH)

Share Price is delayed by 15 minutes
Get Live Data
392.50    -2.50 (-0.63%)
Bid:
390.00
Ask:
395.00
Spread: 5.00 (1.282%)
Market Cap: £123.66m
PGH Live PriceLast checked at - London Stock Exchange

Intraday Personal Group Share Chart

H1 2025 Trading Update

23 Jul 2025 07:00

RNS Number : 1321S
Personal Group Holdings PLC
23 July 2025
 

 23 July 2025

 

PERSONAL GROUP HOLDINGS PLC

("Personal Group", "Company" or "Group")

 

H1 2025 Trading Update

Strong revenue growth across divisions and trading in line with market expectations for full year

Personal Group Holdings Plc (AIM: PGH), the workforce benefits and insurance provider, is pleased to provide the following update for the six-month period ended 30 June 2025 ("H1 2025").

 

Financial Highlights

 

·

Group revenue up 11% to £23.3m (H1 2024: £21.0m), with >90% from recurring revenue sources

·

Adjusted EBITDA* up 41% to £5.5m (H1 2024: £3.9m)

·

Growing levels of recurring revenues, providing good visibility for the full year ("FY 2025") and beyond

Insurance Annualised Premium Income ("API") increased by 12% to £38.0m (H1 2024: £33.8m)

Benefits Platform Annual Recurring Revenue ("ARR") increased by 10% to £6.9m (H1 2024: £6.3m)

Pay & Reward ARR increase 6% to £0.76m (H1 2024: £0.71m)

·

Record new H1 insurance sales of £7.4m API up 7% on previous year (H1 2024: £6.9m)

·

Continued high retention rates across all areas of the business

·

Strong balance sheet and liquidity with a cash position of £26.9m as at 30 June 2025 (31 December 2024: £27.4m) and no debt

 

* Adjusted EBITDA is defined as earnings before interest, tax, depreciation, amortisation of intangible assets, goodwill impairment, share-based payment expenses, profit or loss on disposal of subsidiaries, corporate acquisition costs and restructuring costs.

 

Operational Highlights  

 

Affordable Insurance

Insurance sales continue to grow, delivering another record month, quarter and half year, with annualised insurance sales up 7% to £7.4m (2024: £6.9m). Insurance API increased 12% to £38.0m (30 June 2024: £36.0m), underpinned by strong customer retention levels of over 80% year-on-year. Claims levels in H1 2025 remained consistent, as expected.

 

The Group has had a number of new customer wins in the period, resulting from its reinvigorated go to market efforts, unique face-to-face sales model and relevance of offering, increasing the amount of addressable potential employees and providing the opportunity for future revenue growth.

 

The Group continues to explore opportunities to expand its insurance offering and increase its routes to market. As part of this, digital insurance has been identified as a potential new growth avenue, with the development of the product progressing to plan and a proof of concept currently under trial with several customers. Work has also commenced on a Group cash plan, which is expected to launch later in the year.

 

Benefits & Rewards

The Group's digital benefits platform, Hapi and its SME-focused offering in partnership with Sage Group plc: Sage Employee Benefits ("SEB"), has experienced further ARR growth in the period of 10% to £6.9m as at 30 June 2025 (30 June 2024: £6.3m).

 

With the migration to the new Hapi platform now complete, initiatives are well progressed to increase this growth rate, including the previously announced expanded partnership with Sage, which includes the ability to offer SEB across multiple different solutions within Sage's portfolio. The first new territory launch of SEB, into the Republic of Ireland, commenced at the start of H2 2025.

 

The Group continues to explore further partnerships to target additional market sectors, with the first new partner, EB Now, an employee benefits provider for the SME market, signed in H1 2025 and due to go live during H2 2025.

 

The Pay & Reward division enjoyed further customer success, securing contracts with De Beers Group, Financial Services Compensation Scheme, the European Tour and the British Medical Association.

 

Outlook

 

Personal Group benefits from increasing levels of recurring revenues, a growing product offering and expanding partner programme, supported by a strong balance sheet. These factors, combined with the continued strong Insurance performance in H1 2025, provide the Board with confidence that trading remains in line with market expectations for the full year.

 

Paula Constant, Chief Executive of Personal Group, commented: "Momentum has continued to build across the business, with another record period for insurance sales, and new customers and partners secured. Our consistent growth speaks to the value provided by our offerings and growing market opportunity, underpinned by our strategic progress. Personal Group has all the ingredients to accelerate growth, with a strengthened senior leadership team, streamlined operations, and reinvigorated sales approach. We are confident in continuing our progress in the second half, and have line of sight to achieving our aspirations to deliver in excess of £100m revenues, Group EBITDA of £30m and SaaS ARR of £20m, by 2030."

 

For more information please contact:

 

 

 

Personal Group Holdings Plc

 

Paula Constant (CEO) / Sarah Mace (CFO)

Via Alma

 

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

 

Max Hartley / Harry Rees

+44 (0)20 7523 8000

Alma Strategic Communications

+44 (0)20 3405 0205

Caroline Forde / Kinvara Verdon / Rose Docherty

personalgroup@almastrategic.com 

 

Notes to Editors

 

Personal Group Holdings Plc (AIM: PGH) is a workforce benefits and health insurance provider. Its vision is to be the champion of affordable and accessible insurance and benefits, keeping businesses and their employees happy, healthy and protected. The Group is proud to support the health and wellbeing of c. 1.25 million UK employees.

 

The Group's insurance provides employees with access to affordable, individual policies for hospitalrecovery and death benefit plans. The Group's award-winning benefits platform, Hapi, brings together extensive employee benefits, discounts and rewards, in one responsive platform. As well as being sold direct to employers, the Hapi platform supports Sage's Employee Benefits offerings for SMEs.

 

This comprehensive range of offerings, powerful platform and unique sales model of face-to-face, one-to-one engagement with employees, provides Personal Group with a strong market position from which to grow. 

 

Head-quartered in Milton Keynes, the Group has built an extensive blue-chip customer list over its 40-year history, including Airtanker, B & Q, Barchester Healthcare, British Transport Police, British Airways, Merseyrail, Office of National Statistics, Randstad, Royal Mail Group, The Royal Mint, Stagecoach Group plc, and The University of York

 

For further information on the Group please see www.personalgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDRRUDDGUD
Date   Source Headline
28th May 20263:51 pmRNSGrant of LTIP
12th May 20263:30 pmRNSDirector/PDMR Shareholding
7th May 20264:02 pmRNSResult of AGM
7th May 20267:00 amRNSAGM Statement
23rd Apr 20267:00 amRNSExercise of Options, PDMR and Total Voting Rights
13th Apr 20267:00 amRNSAGM Notification
1st Apr 20262:00 pmRNSHolding(s) in Company
24th Mar 20267:02 amRNSPreliminary Results and Final Dividend
23rd Mar 20267:00 amRNS-RNew Insurance Partnership
12th Mar 20267:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 202612:00 pmRNSHolding(s) in Company
28th Jan 202611:00 amRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update & Notice of Full Year Results
21st Jan 20262:45 pmRNSHolding(s) in Company
21st Jan 202611:00 amRNSHolding(s) in Company
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:00 pmRNSHolding(s) in Company
2nd Dec 20257:00 amRNSCFO Succession
24th Nov 20257:00 amRNSNotification of major holdings
7th Nov 20255:41 pmRNSDirector/PDMR Shareholding
30th Sep 20255:00 pmRNSHolding(s) in Company
16th Sep 20257:00 amRNSInterim Results
27th Aug 20257:00 amRNSNotice of Results and Presentations
23rd Jul 20257:00 amRNSH1 2025 Trading Update
18th Jul 202510:18 amRNSReplacement: PDMR Share Dealing
14th Jul 20254:09 pmRNSPDMR Share Dealing
27th May 20257:00 amRNS-RPGH Presenting at the Mello 2025 Conference
19th May 20255:13 pmRNSDirector/PDMR Shareholding
15th May 20253:58 pmRNSDirector/PDMR Dealings
8th May 20255:10 pmRNSResult of AGM
8th May 20257:00 amRNSAGM Trading Statement
29th Apr 202511:51 amRNSExercise of Options, PDMR Dealing and TVR
28th Apr 20255:03 pmRNSHolding(s) in Company
9th Apr 20257:00 amRNSGrant of LTIP
8th Apr 20257:00 amRNSAGM Notification
7th Apr 20254:23 pmRNSDirector/PDMR Dealings
1st Apr 20257:00 amRNSDirectorate Change
27th Mar 20257:00 amRNSPartnership Renewal & Expansion with Sage Group
25th Mar 20257:00 amRNSPreliminary Results and Final Dividend
14th Mar 20257:00 amRNSNotice of Analyst and Investor Presentation
24th Feb 20256:00 pmRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Update & Notice of Full Year Results
3rd Jan 20257:00 amRNSPDMR Share Dealing
13th Nov 20243:45 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20244:19 pmRNSNotification of major holdings
3rd Oct 20244:16 pmRNSNotification of major holdings
30th Sep 20244:25 pmRNSNotification of major holdings
24th Sep 20247:00 amRNSInterim Results
16th Sep 20247:00 amRNSNotice of Results & Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.